Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06642948
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-13
Brief Title:
AI-based Skeleton Recognition System for Rehabilitation Exercise in Breast Cancer Survivors A Randomized Controlled Trial
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Evaluating the Efficacy of Structured Exercise Interventions in Alleviating Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Survivors A Randomized Controlled Trial
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
AiRE-MS
Brief Summary:
This study aims to develop and evaluate an artificial intelligence AI-based skeletal recognition system designed to support real-time interactive rehabilitation exercise RE programs The goal is to mitigate musculoskeletal symptoms associated with endocrine therapy in breast cancer survivorsEndocrine therapy remains a cornerstone in the treatment of hormone receptor-positive breast cancer typically extending over 5 to 10 years While the therapeutic benefits of endocrine therapy are well established agents such as aromatase inhibitors frequently induce musculoskeletal symptoms MS including joint pain stiffness particularly morning stiffness carpal tunnel syndrome tenosynovitis myalgia and muscle weakness These symptoms which may be continuous or intermittent can affect both central spine hips shoulders and peripheral joints elbows wrists knees feet severely compromising patients quality of life QoL Although physical exercise has been demonstrated to alleviate these symptoms adherence to adequate exercise regimens remains suboptimal among patients Furthermore there is no consensus on the optimal type duration or intensity of exercise interventions and standardized protocols are lacking Recognizing exercise as a long-term behavior we are developing a home-based AI-assisted rehabilitation program tailored to the specific needs of patients undergoing endocrine therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None